Don't rain on Anitbotters parade Miso..
Pharmasset's market cap in 2007 was $364M. It took one or two non commercialized late stage molecules to propel it to $11 billion 5 years later.
Maybe our HRV/RSV combo will do the trick in a couple of years time. Or the HCV drug if we keep it away from Biocryst.
Dare to dream Antibotter.